NCT03399084View on ClinicalTrials.gov

A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia

PHASE1CompletedINTERVENTIONAL

Enrollment

71

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

January 15, 2019

Study Completion Date

January 15, 2019

Conditions

Iron Deficiency Anemia

Interventions

DRUG

Ferric carboxymaltose

750 mg/15 mL

Trial Locations (1)

33143

Sandoz Investigative Site, Miami

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sandoz

INDUSTRY